Literature DB >> 31150712

Nonscarring alopecia in systemic lupus erythematosus: A cross-sectional study with trichoscopic, histopathologic, and immunopathologic analyses.

Kumutnart Chanprapaph1, Siriorn Udompanich1, Yingluck Visessiri2, Pintip Ngamjanyaporn3, Poonkiat Suchonwanit4.   

Abstract

BACKGROUND: Nonscarring alopecia in systemic lupus erythematosus (SLE) is widely recognized, but reports on its clinical, trichoscopic, histopathologic, and direct immunofluorescence (DIF) features are still limited.
OBJECTIVE: To summarize the different clinical patterns, trichoscopic, histopathologic, and DIF features of nonscarring alopecia in SLE and to prove its association with disease activity.
METHODS: Patients with SLE with and without nonscarring alopecia had full physical/trichoscopic examination and scalp biopsy. Their disease activity scores and laboratory data were evaluated and statistically analyzed.
RESULTS: Thirty-two patients with SLE had different patterns of nonscarring alopecia, including mild diffuse alopecia (43.8% [n = 14]), severe diffuse alopecia (15.6% [n = 5]), patchy alopecia (28.1% [n = 9]), and lupus hair (12.5% [n = 4]). The most common trichoscopic findings were arborizing/interconnecting vessels (83% [n = 26]). Histopathologic examination showed interface changes along the dermoepidermal junction (87.5% [n = 28]) and follicular epithelium (40.6% [n = 13]). On DIF, homogeneous granular deposition was detected along the dermoepidermal junction (78.1% [n = 25]) and follicular epithelium (78.1% [n = 25]). When compared with 10 patients with SLE without alopecia, there was a significantly higher SLE Disease Activity Index 2000 score and prevalence of proteinuria (>1 g/d). LIMITATIONS: This was a small, cross-sectional, single-center study.
CONCLUSIONS: Nonscarring alopecia in SLE shows lupus erythematosus-specific changes on histology and DIF. Hair loss in SLE can be considered as an indicator of active disease.
Copyright © 2019 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DIF; LE; SLE; alopecia; dermoscopy; direct immunofluorescence; hair loss; histology; histopathology; systemic lupus erythematosus; trichoscopy

Year:  2019        PMID: 31150712     DOI: 10.1016/j.jaad.2019.05.053

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  11 in total

1.  Sleep quality in men with androgenetic alopecia.

Authors:  Somprasong Liamsombut; Cherrin Pomsoong; Chaninan Kositkuljorn; Kanchana Leerunyakul; Visasiri Tantrakul; Poonkiat Suchonwanit
Journal:  Sleep Breath       Date:  2022-04-25       Impact factor: 2.816

2.  Epidemiological, Clinical, Trichoscopic, and Histopathological Features of Lupus Erythematous Mimicking Alopecia Areata: A Multicenter Retrospective Study.

Authors:  Daniel Fernandes Melo; Paulo Müller Ramos; Matilde Iorizzo; Caren Dos Santos Lima; Erica Baptista Pinto; Rita Fernanda Cortez de Almeida; Carla Jorge Machado; Michela Starace
Journal:  Skin Appendage Disord       Date:  2022-01-03

3.  Variation of Hair Follicle Counts among Different Scalp Areas: A Quantitative Histopathological Study.

Authors:  Suthinee Rutnin; Kumutnart Chanprapaph; Kallapan Pakornphadungsit; Kanchana Leerunyakul; Yingluck Visessiri; Smith Srisont; Poonkiat Suchonwanit
Journal:  Skin Appendage Disord       Date:  2021-09-01

4.  A Case of Extensive Mass on the Scalp with Alopecia.

Authors:  Cherrin Pomsoong; Poonkiat Suchonwanit
Journal:  Skin Appendage Disord       Date:  2021-09-02

5.  Discoid lupus erythematosus precipitated by topical diphencyprone immunotherapy for alopecia areata.

Authors:  Hui Ling Foo; Joyce Siong See Lee; Etienne Cho Ee Wang
Journal:  JAAD Case Rep       Date:  2020-06-04

6.  Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib.

Authors:  Yu-Lan Chen; Li-Xiong Liu; Qin Huang; Xue-Ying Li; Xiao-Ping Hong; Dong-Zhou Liu
Journal:  Front Immunol       Date:  2021-04-14       Impact factor: 7.561

7.  Intramuscular Corticosteroid Therapy in the Treatment of Alopecia Areata: A Time-to-Event Analysis.

Authors:  Kumutnart Chanprapaph; Cherrin Pomsoong; Chaninan Kositkuljorn; Poonkiat Suchonwanit
Journal:  Drug Des Devel Ther       Date:  2022-01-07       Impact factor: 4.162

8.  Prevalence and Risk Factors Associated with the Occurrence of Autoimmune Diseases in Patients with Alopecia Areata.

Authors:  Kumutnart Chanprapaph; Thipprapai Mahasaksiri; Chaninan Kositkuljorn; Kanchana Leerunyakul; Poonkiat Suchonwanit
Journal:  J Inflamm Res       Date:  2021-09-22

Review 9.  Measuring Patient Quality of Life Following Treatment for Alopecia.

Authors:  Kunlawat Thadanipon; Poonkiat Suchonwanit
Journal:  Patient Prefer Adherence       Date:  2021-07-16       Impact factor: 2.711

Review 10.  Alopecia Areata: An Autoimmune Disease of Multiple Players.

Authors:  Poonkiat Suchonwanit; Chaninan Kositkuljorn; Cherrin Pomsoong
Journal:  Immunotargets Ther       Date:  2021-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.